Skip to the page

Data / Form D filings / Clene Inc.

Clene Inc.: Form D filings

Clene Inc., a pharmaceuticals company in Salt Lake City, UT, filed 2 Form D notices with the SEC between 2021 and 2024. The latest, on October 9, 2024, reports $7.3 million sold of a $7.3 million offering to 13 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
6550 SOUTH MILLROCK DRIVE, SUITE G50, Salt Lake City, UT, 84121
Phone
(801) 676-9695
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1822791

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 9, 2024New notice$7,310,060$7,310,06013Oct 1, 2024sec.gov
May 26, 2021New notice$9,250,000$9,250,0008May 24, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Alison Dee MoscaDirector
Mark Dee MortensonExecutive Officer
Robert Dee EtheringtonExecutive Officer, Director
Shalom T. JacobovitzDirector
Morgan Dee BrownExecutive Officer
David Dee MatlinDirector
Jonathon T. GayDirector
Reed Neil WilcoxDirector
Vallerie V. McLaughlinDirector
Matthew V. KiernanDirector
Arjun Dee DesaiDirector

Every Form D from the week of Oct 7, 2024 · All recent filings in Utah · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Clene Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.